PG
Pharming Group NV
🇺🇸XNAS.PHARUnited StatesHealthcare
$10.72USDup +0.17 (+1.61%)OpenDelayed3:19 PM
Price$10.72+0.17 (+1.61%)
Profile
- Healthcare
- Biotechnology
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- US71716E1055
- CUSIP
- Not reported
Company
- Employees
- 407
- Headquarters
- Leiden, United States
- Website
- https://www.pharming.com
- CEO
- Mr. Fabrice Chouraqui M.B.A., Ph.D., Pharm.D.
Market
- Shares outstanding
- 70.8M
- Market cap
- $758.74M
Key dates
- Next earnings
- Nov 5, 2026
Highlights
- Market cap
- $739.63M
- EPS LTM
- $0.13calculatedCalculated by Finzer, not reported by the data provider.
- P/E LTM
- 81.82calculatedCalculated by Finzer, not reported by the data provider.
- Div yield
- 0%
Fundamentals (LTM)
- Revenue
- $366.45M-99.61%down year on year
- Net income
- $9.27M-99.68%down year on year
- Gross margin
- 86.53%-0.37%down year on year
- Free cash flow
- $31.34M+4.03%up year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.